Acerus Pharmaceuticals (ASPCF) Short Interest Ratio & Short Volume

Short interest is the volume of Acerus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 1,400 shares of ASPCF short. Learn More on Acerus Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASPCF shares currently have a short interest ratio of 2.0. Learn More on Acerus Pharmaceuticals's short interest ratio.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acerus Pharmaceuticals: Orgenesis Inc. (0.13%), China Pharma Holdings, Inc. (2.27%), Matinas Biopharma Holdings, Inc. (3.13%), Can-Fite BioPharma Ltd. (3.74%), Spruce Biosciences, Inc. (0.12%), Affimed (4.46%), Vaccinex, Inc. (0.16%), Palatin Technologies, Inc. (29.27%), Galera Therapeutics, Inc. (0.02%), Bio-Path Holdings, Inc. (0.10%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), Pacific Gas & Electric Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling ASPCF is an investing strategy that aims to generate trading profit from Acerus Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Acerus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASPCF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASPCF, twice per month. The most recent reporting period available is January, 15 2023.